التفاصيل البيبلوغرافية
| العنوان: |
Clinical outcome of coronary stenting after thoracic radiotherapy: a case-control study. |
| المؤلفون: |
Dubois, Christophe L., Pappas, Christos, Belmans, Ann, Erven, Katrien, Adriaenssens, Tom, Sinnaeve, Peter, Coosemans, Mark, Kayaert, Peter, Weltens, Caroline, Desmet, Walter |
| المصدر: |
Heart; May2010, Vol. 96 Issue 9, p678-682, 5p, 2 Charts, 2 Graphs |
| مصطلحات موضوعية: |
LYMPHOMAS, LUNG cancer, BREAST cancer, CORONARY disease, MYOCARDIAL infarction, CARDIAC patients |
| مستخلص: |
Objective Patients with lymphoma, lung or breast neoplasia show significant improvement in their disease-specific survival after radiotherapy (RT), but these benefits may be offset by delayed effects of irradiation of the heart. We compared clinical outcome after coronary stenting in patients with neoplastic disease and previous thoracic RT with matched patients without previous RT. Design Single-centre retrospective case-control study. Patients and methods Each patient with former thoracic RT undergoing coronary stenting between June 1998 and June 2005 was matched to two control patients according to several known prognostic factors (gender, age, available follow-up, stented vessel, drug-eluting stent use, unstable coronary disease, renal insufficiency, diabetes, bifurcational disease, stent length and size and ejection fraction). Main outcome measures Major adverse cardiac events (MACE) were defined as the composite of cardiac death, acute myocardial infarction (AMI) and target lesion revascularisation (TLR) and were assessed at latest follow-up and compared using Cox regression analyses. Results 41 patients underwent coronary stenting at 6±4 years after RT. Clinical outcome at 5±2 years after stenting was compared with outcome in 82 matched patients. For all-cause mortality, the hazard ratio for RT versus no RT was 4.2 (95% CI 1.8 to 9.5; p=0.0006). For cardiac mortality, the estimated hazard ratio was 4.2 (95% CI 1.0 to 17.0; p=0.0451). No significant differences were detected in terms of AMI, TLR, MACE or stent thrombosis. Conclusions Our findings suggest an increased risk of all-cause and cardiac mortality in patients who underwent coronary stent implantation after previous thoracic RT. Verification in larger patient populations is warranted. [ABSTRACT FROM AUTHOR] |
|
Copyright of Heart is the property of BMJ Publishing Group and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
